ArticleJournal of clinical immunology1987

Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC).

C E Sigal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.